106 related articles for article (PubMed ID: 18266871)
1. T cells in amyotrophic lateral sclerosis.
Holmøy T
Eur J Neurol; 2008 Apr; 15(4):360-6. PubMed ID: 18266871
[TBL] [Abstract][Full Text] [Related]
2. Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS.
Habisch HJ; Schwalenstöcker B; Danzeisen R; Neuhaus O; Hartung HP; Ludolph A
Exp Neurol; 2007 Aug; 206(2):288-95. PubMed ID: 17597611
[TBL] [Abstract][Full Text] [Related]
3. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
4. A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis.
Shao H; He Y; Li KC; Zhou X
Mol Biosyst; 2013 Mar; 9(3):398-406. PubMed ID: 23287963
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis.
Sirianni AC; Jiang J; Zeng J; Mao LL; Zhou S; Sugarbaker P; Zhang X; Li W; Friedlander RM; Wang X
J Neurochem; 2015 Sep; 134(5):956-68. PubMed ID: 26031348
[TBL] [Abstract][Full Text] [Related]
6. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
[TBL] [Abstract][Full Text] [Related]
7. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
Van den Bosch L
Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
9. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapy in amyotrophic lateral sclerosis.
Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
[TBL] [Abstract][Full Text] [Related]
11. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis.
Miyazaki K; Ohta Y; Nagai M; Morimoto N; Kurata T; Takehisa Y; Ikeda Y; Matsuura T; Abe K
J Neurosci Res; 2011 May; 89(5):718-28. PubMed ID: 21337372
[TBL] [Abstract][Full Text] [Related]
12. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis.
Nonneman A; Robberecht W; Van Den Bosch L
Neurodegener Dis Manag; 2014; 4(3):223-39. PubMed ID: 25095817
[TBL] [Abstract][Full Text] [Related]
13. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
Deeb O; Nabulsi M
Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
[TBL] [Abstract][Full Text] [Related]
14. Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Mimoto T; Morimoto N; Miyazaki K; Kurata T; Sato K; Ikeda Y; Abe K
Brain Res; 2012 Dec; 1488():123-31. PubMed ID: 23063459
[TBL] [Abstract][Full Text] [Related]
15. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
Philips T; Robberecht W
Lancet Neurol; 2011 Mar; 10(3):253-63. PubMed ID: 21349440
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
18. Calcium dysregulation in amyotrophic lateral sclerosis.
Grosskreutz J; Van Den Bosch L; Keller BU
Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097
[TBL] [Abstract][Full Text] [Related]
19. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide.
Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR
Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872
[TBL] [Abstract][Full Text] [Related]
20. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
